![ISPOR Europe 2024 – May 5-8. Register now.]({"type":"image" , "src" : "/sda/112342/JournalAd-ISPOR-2024-Leaderboard.jpg"})
Citations (54)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Leif R Erhardt. (2007) Rationale for multiple risk intervention: The need to move from theory to practice. Vascular Health and Risk Management 3:6, pages 985-997.
Read now
Read now
Vasilios G Athyros, Konstantinos Tziomalos, Dimitri P Mikhailidis, Efstathios D Pagourelias, Anna I Kakafika, Athanasios Skaperdas, Apostolos Hatzitolios & Asterios Karagiannis. (2007) Do we need a statin-nicotinic acid-aspirin mini-polypill to treat combined hyperlipidaemia?. Expert Opinion on Pharmacotherapy 8:14, pages 2267-2277.
Read now
Read now
Articles from other publishers (52)
Szu-Han Chiu, Frank L. Douglas, Jia-Ru Chung, Kuang-Yih Wang, Chao-Fang Chu, Hsia-Yun Chou, Wei-Chih Huang, Tian-Yu Wang, Wen-Wen Chen, Min-Chung Shen, Feng-Cheng Liu & Po-Jen Hsiao. (2023) Evaluation of the safety and potential lipid-lowering effects of oral hydrogen-rich coral calcium (HRCC) capsules in patients with metabolic syndrome: a prospective case series study. Frontiers in Nutrition 10.
Crossref
Crossref
Eun-Sook Sung & Jonghoon Park. (2023) Physical activity levels and energy intake according to the presence of metabolic syndrome among single-household elderly in Korea: Korean National Health and Nutrition Examination Survey 2016–2018. Frontiers in Public Health 11.
Crossref
Crossref
Arielys Mendoza & Jason Karch. (2022) Keeping the beat against time: Mitochondrial fitness in the aging heart. Frontiers in Aging 3.
Crossref
Crossref
M. Imenshahidi & H. Hossenzadeh. (2022) Effects of glycine on metabolic syndrome components: a review. Journal of Endocrinological Investigation 45:5, pages 927-939.
Crossref
Crossref
Felippe Steven Louis G. Delos Reyes, Adrian Carlo C. Mamaril, Trisha Joy P. Matias, Mary Kathleen V. Tronco, Gabriel R. Samson, Nyczl D. Javier, Ailyn Fadriquela, Jayson M. Antonio & Ma Easter Joy V. Sajo. (2021) The Search for the Elixir of Life: On the Therapeutic Potential of Alkaline Reduced Water in Metabolic Syndromes. Processes 9:11, pages 1876.
Crossref
Crossref
Satomi Kagota, Kana Maruyama-Fumoto, John J. McGuire & Kazumasa Shinozuka. (2021) A Sodium Glucose Cotransporter 2 Inhibitor Fails to Improve Perivascular Adipose Tissue-Mediated Modulation of Vasodilation and Cardiac Function in Rats With Metabolic Syndrome. Journal of Cardiovascular Pharmacology and Therapeutics 26:5, pages 480-489.
Crossref
Crossref
Vimala Ananthy, Raman Palanyswamy Priyadharsini & Umamaheswari Subramanian. (2021) Pathogenesis, Diagnosis, and Management of Metabolic Syndrome: A Comprehensive Review. SBV Journal of Basic, Clinical and Applied Health Science 4:2, pages 39-45.
Crossref
Crossref
O. V. Vlyubchak, S. V. Dutova & I. P. Romanova. (2021) Features of antihypertensive pharmacotherapy in patients with metabolic syndrome and diabetes mellitus. The Siberian Journal of Clinical and Experimental Medicine 36:2, pages 36-44.
Crossref
Crossref
Elisa Cicerello, Matteo Ciaccia, Gian D. Cova & Mario S. Mangano. (2021) The new patterns of nephrolithiasis: What has been changing in the last millennium?. Archivio Italiano di Urologia e Andrologia 93:2, pages 195-199.
Crossref
Crossref
Kei HiguchiJonathan J. KopelSathish Sivaprakasam, Valeria Jaramillo-MartinezR. Bryan SuttonIna L. UrbatschVadivel Ganapathy. (2020) Functional analysis of a species-specific inhibitor selective for human Na+-coupled citrate transporter (NaCT/SLC13A5/mINDY). Biochemical Journal 477:21, pages 4149-4165.
Crossref
Crossref
Filip Przerwa, Arnold Kukowka & Izabela Uzar. (2020)
Ballota nigra
L. – an overview of pharmacological effects and traditional uses
. Herba Polonica 66:3, pages 56-65.
Crossref
Crossref
Diego Armando Maldonado-Torres, D. Alejandro Fernández-Velasco, Gema Morales-Olán, Flor de Fátima Rosas-Cárdenas & Silvia Luna-Suárez. (2020) Modification of Vegetable Proteins to Release Bioactive Peptides Able to Treat Metabolic Syndrome—In Silico Assessment. Applied Sciences 10:7, pages 2604.
Crossref
Crossref
Helen H. Wang, Dong Ki Lee, Min Liu, Piero Portincasa & David Q.-H. Wang. (2020) Novel Insights into the Pathogenesis and Management of the Metabolic Syndrome. Pediatric Gastroenterology, Hepatology & Nutrition 23:3, pages 189.
Crossref
Crossref
Martha Guevara‐Cruz, Adriana G. Flores‐López, Miriam Aguilar‐López, Mónica Sánchez‐Tapia, Isabel Medina‐Vera, Daniel Díaz, Armando R. Tovar & Nimbe Torres. (2019) Improvement of Lipoprotein Profile and Metabolic Endotoxemia by a Lifestyle Intervention That Modifies the Gut Microbiota in Subjects With Metabolic Syndrome. Journal of the American Heart Association 8:17.
Crossref
Crossref
Mohamed Zaiou. 2019. Reviews on Biomarker Studies of Metabolic and Metabolism-Related Disorders. Reviews on Biomarker Studies of Metabolic and Metabolism-Related Disorders
177
191
.
Elaine Wat, Yanping Wang, Ken Chan, Hon Wai Law, Chi Man Koon, Kit Man Lau, Ping Chung Leung, Choly Yan & Clara Bik San Lau. (2018) An in vitro and in vivo study of a 4-herb formula on the management of diet-induced metabolic syndrome. Phytomedicine 42, pages 112-125.
Crossref
Crossref
Dana E. Lowry, Peri H. Fenwick, Kaitlin Roke, Khursheed Jeejeebhoy, Rupinder Dhaliwal, Paula Brauer, Dawna Royall, Angelo Tremblay, Doug Klein & David M. Mutch. (2018) Variants in <b><i>APOA5</i></b> and <b><i>ADIPOQ</i></b> Moderate Improvements in Metabolic Syndrome during a One-Year Lifestyle Intervention. Lifestyle Genomics 11:2, pages 80-89.
Crossref
Crossref
Clint T. Miller, Steve F. Fraser, Steve E. Selig, Toni Rice, Mariee Grima, Nora E. Straznicky, Itamar Levinger, Elisabeth A. Lambert, Daniel J. van den Hoek & John B. Dixon. (2016) The functional and clinical outcomes of exercise training following a very low energy diet for severely obese women: study protocol for a randomised controlled trial. Trials 17:1.
Crossref
Crossref
TAKAMASA TSUZUKI, TOSHINORI YOSHIHARA, NORIKO ICHINOSEKI-SEKINE, YURI TAKAMINE, RYO KAKIGI, HIROYUKI KOBAYASHI & HISASHI NAITO. (2016) Long-Lasting Effects of Early-Onset Exercise on the Prevention of Obesity and Its Related Lifestyle Diseases. Juntendo Medical Journal 62:Suppl.1, pages 151-155.
Crossref
Crossref
M.S. Costamagna, I.C. Zampini, M.R. Alberto, S. Cuello, S. Torres, J. Pérez, C. Quispe, G. Schmeda-Hirschmann & M.I. Isla. (2016) Polyphenols rich fraction from Geoffroea decorticans fruits flour affects key enzymes involved in metabolic syndrome, oxidative stress and inflammatory process. Food Chemistry 190, pages 392-402.
Crossref
Crossref
Eunice Mah, Teryn N Sapper, Chureeporn Chitchumroonchokchai, Mark L Failla, Kevin E Schill, Steven K Clinton, Gerd Bobe, Maret G Traber & Richard S Bruno. (2015) α-Tocopherol bioavailability is lower in adults with metabolic syndrome regardless of dairy fat co-ingestion: a randomized, double-blind, crossover trial. The American Journal of Clinical Nutrition 102:5, pages 1070-1080.
Crossref
Crossref
Takamasa Tsuzuki, Shohei Shinozaki, Hideko Nakamoto, Masao Kaneki, Sataro Goto, Kentaro Shimokado, Hiroyuki Kobayashi & Hisashi Naito. (2015) Voluntary Exercise Can Ameliorate Insulin Resistance by Reducing iNOS-Mediated S-Nitrosylation of Akt in the Liver in Obese Rats. PLOS ONE 10:7, pages e0132029.
Crossref
Crossref
Yee V. Wong, Paul Cook & Bhaskar K. Somani. (2015) The Association of Metabolic Syndrome and Urolithiasis. International Journal of Endocrinology 2015, pages 1-9.
Crossref
Crossref
Francesca Pistollato & Maurizio Battino. (2014) Role of plant-based diets in the prevention and regression of metabolic syndrome and neurodegenerative diseases. Trends in Food Science & Technology 40:1, pages 62-81.
Crossref
Crossref
Keonie Moore. (2014) Metabolic syndrome: A case report for collaborative care. Advances in Integrative Medicine 1:1, pages 44-47.
Crossref
Crossref
Silke Krol, Richard Macrez, Fabian Docagne, Gilles Defer, Sophie Laurent, Masoud Rahman, Mohammad J. Hajipour, Patrick G. KehoeMorteza Mahmoudi. (2012) Therapeutic Benefits from Nanoparticles: The Potential Significance of Nanoscience in Diseases with Compromise to the Blood Brain Barrier. Chemical Reviews 113:3, pages 1877-1903.
Crossref
Crossref
John C. LaRosa & John B. Kostis. 2013. Hypertension: A Companion to Braunwald’s Heart Disease. Hypertension: A Companion to Braunwald’s Heart Disease
320
326
.
Sheldon Chen, Charbel Khoury & Fuad N. Ziyadeh. 2013. Seldin and Giebisch's The Kidney. Seldin and Giebisch's The Kidney
2605
2632
.
James Rippe & Theodore AngelopoulosPeter Grandjean. 2012. Obesity. Obesity
311
342
.
Patrick B. Massey. 2012. Integrative Medicine. Integrative Medicine
821
827.e2
.
Y. A. Rajabally. (2011) Neuropathy and impaired glucose tolerance: an updated review of the evidence. Acta Neurologica Scandinavica 124:1, pages 1-8.
Crossref
Crossref
Richard A. Krasuski, Ganesh P. Devendra, George Cater, Richard A. Krasuski & Edwin J. Whitney. (2011) The Effect of Gemfibrozil, Niacin and Cholestyramine Combination Therapy on Metabolic Syndrome in the Armed Forces Regression Study. The American Journal of the Medical Sciences 341:5, pages 378-382.
Crossref
Crossref
Xuefeng Han & Jun Ren. (2010) Caloric restriction and heart function: is there a sensible link?. Acta Pharmacologica Sinica 31:9, pages 1111-1117.
Crossref
Crossref
Stephen R. Spindler. (2010) Caloric restriction: From soup to nuts. Ageing Research Reviews 9:3, pages 324-353.
Crossref
Crossref
Pranav Dalal & Rohit Arora. (2010) Statin Therapy in South Asians—Facts and Future. American Journal of Therapeutics 17:2, pages e41-e47.
Crossref
Crossref
Laura Castello, Teresa Froio, Marco Maina, Gabriella Cavallini, Fiorella Biasi, Gabriella Leonarduzzi, Alessio Donati, Ettore Bergamini, Giuseppe Poli & Elena Chiarpotto. (2010) Alternate-day fasting protects the rat heart against age-induced inflammation and fibrosis by inhibiting oxidative damage and NF-kB activation. Free Radical Biology and Medicine 48:1, pages 47-54.
Crossref
Crossref
Stephen R. Spindler. 2010. The Future of Aging. The Future of Aging
367
438
.
L. López Penabad, P. Roig Rico, J. Robert Gates & J. Merino Sánchez. (2009) Protocolo terapéutico del síndrome metabólico. Medicine - Programa de Formación Médica Continuada Acreditado 10:40, pages 2742-2745.
Crossref
Crossref
Muthiah Vaduganathan, Carlos L. Alviar, Mehmet E. Arikan, Armando Tellez, Sadishar Guthikonda, Timothy DeLao, Juan F. Granada, Neal S. Kleiman, Christie M. Ballantyne & Eli I. Lev. (2008) Platelet reactivity and response to aspirin in subjects with the metabolic syndrome. American Heart Journal 156:5, pages 1002.e1-1002.e7.
Crossref
Crossref
David J. Lloyd, Jocelyn McCormick, Joan Helmering, Ki Won Kim, Minghan Wang, Preston Fordstrom, Stephen A. Kaufman, Richard A. Lindberg & Murielle M. Véniant. (2008)
Generation and characterization of two novel mouse models exhibiting the phenotypes of the metabolic syndrome: Apob48
−/−
Lep
ob/ob
mice devoid of ApoE or Ldlr
. American Journal of Physiology-Endocrinology and Metabolism 294:3, pages E496-E505.
Crossref
Crossref
Gunter Wolf, Kumar Sharma & Fuad N. Ziyadeh. 2008. Seldin and Giebisch's The Kidney. Seldin and Giebisch's The Kidney
2215
2233
.
Arthur H. Friedlander, Jane Weinreb, Ida Friedlander & John A. Yagiela. (2007) Metabolic syndrome. The Journal of the American Dental Association 138:2, pages 179-187.
Crossref
Crossref
P. Chan, I.-M. Liu, T.-F. Tzeng, T.-L. Yang & J.-T. Cheng. (2007) Mechanism for blockade of angiotensin subtype 1 receptors to lower plasma glucose in streptozotocin-induced diabetic rats. Diabetes, Obesity and Metabolism 9:1, pages 39-49.
Crossref
Crossref
John C. LaRosa. 2007. Hypertension. Hypertension
418
425
.
Patrick B. Massey. 2007. Integrative Medicine. Integrative Medicine
999
1007
.
David W. BusijaAllison W. MillerPrasad KatakamBenedek Erdős. (2006) Adverse Effects of Reactive Oxygen Species on Vascular Reactivity in Insulin Resistance. Antioxidants & Redox Signaling 8:7-8, pages 1131-1140.
Crossref
Crossref
J. M. Dhahbi, T. Tsuchiya, H.-J. Kim, P. L. Mote & S. R. Spindler. (2006) Gene Expression and Physiologic Responses of the Heart to the Initiation and Withdrawal of Caloric Restriction. The Journals of Gerontology Series A: Biological Sciences and Medical Sciences 61:3, pages 218-231.
Crossref
Crossref
W. Dallas HallLaurence O. WatkinsJackson T. WrightJr.Jr., Nanette K. WengerShiriki K. KumanyikaJames R. GavinIIIIIIKeith C. FerdinandKarol WatsonLuther T. ClarkJohn M. FlackJames W. ReedElla W. HortonElijah Saunders. (2006) The Metabolic Syndrome: Recognition and Management. Disease Management 9:1, pages 16-33.
Crossref
Crossref
M C MarshallJrJr. (2005) Diabetes in African Americans. Postgraduate Medical Journal 81:962, pages 734-740.
Crossref
Crossref
Saad Hafidh, Neelavathi Senkottaiyan, Martin A. Alpert & Daniel Villarreal. (2005) Management of the Metabolic Syndrome. The American Journal of the Medical Sciences 330:6, pages 343-351.
Crossref
Crossref
E. N. Liberopoulos, D. P. Mikhailidis & M. S. Elisaf. (2005) Diagnosis and management of the metabolic syndrome in obesity. Obesity Reviews 6:4, pages 283-296.
Crossref
Crossref
P. LORIA, A. LONARDO, L. CARULLI, A. M. VERRONE, M. RICCHI, S. LOMBARDINI, A. RUDILOSSO, S. BALLESTRI & N. CARULLI. (2005) Review article: the metabolic syndrome and non-alcoholic fatty liver disease. Alimentary Pharmacology and Therapeutics 22:s2, pages 31-36.
Crossref
Crossref